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Urinary Cadmium and Blood Pressure:
Results from the NHANES 11 Survey
by Alice S. Whittemore,* Yasamin DiCiccio,*
and George Provenzanot
Relationships between urinary cadmium levels and blood pressure were examined in a sample of
951 adult menand womenwhoparticipated inthe SecondNational Health andNutritional Examina-
tion Survey (NHANES II). Among allparticipants, positive relationships were seenbetweenurinary
cadmium levels and both systolic and diastolic blood pressure (p < 0.05 andp < 0.01, respectively),
afteradjusting forage, sex, race, relative bodyweight, smoking status, andhypertensive medication
use. However, analyses for subgroups determined by sex and smoking status were inconsistent.
Among current smokers, urinary cadmium levels were significantly positively associated with both
systolic and diastolic blood pressure for women, and with diastolic blood pressure for men. Yet
among former smokersandlifelongnonsmokers ofboth sexes, urinary cadmium was notsignificant-
lyassociatedwitheithersystolic ordiastolicbloodpressure. Evidencethatsomehypertensive medi-
cations increase urinary cadmium excretion suggeststhatthepositive associations seenamong cur-
rent smokers mayreflect highurinary cadmiumlevels amonghypertensives inducedbyhypertensive
treatment. After treated hypertensives were removed from the analysis, regression coefficients re-
latingbloodpressure tocadmium droppedbyafactoroftwoand lost statistical significance. We con-
cludethatthepresent dataprovidelittle support foracausalassociationbetweensystemiccadmium
and hypertension at nonoccupational exposure levels. Further, conflicting results ofprevious stud-
ies may reflect failure to control adequately for age, smoking status, and hypertensive treatment.
Introduction
Animal studies of long-term cadmium exposures
(1-6) and occupational studies (7) suggest that expo-
sure to high cadmium levels may increase blood pres-
sure. However, effects of exposures to lower cadmium
levels that are typical of nonoccupationally exposed
populations are unclear, with some studies showing a
positive association (8-12) and others showing no as-
sociation (13,14) or even a negative association (15,16).
Thepotentialfor increased exposure tocadmium as an
environmental contaminant, coupled with the ele-
ment's tendency to accumulate in the body, has raised
concern that exposures to current environmental lev-
els may themselves contribute to hypertension in the
general population (17). Cadmium from the soil tends
to accumulate in many vegetable crops, so that in-
creasedapplicationofmunicipal sludgetoagricultural
land may cause increased cadmium exposure through
food ingestion (18,19).
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Here wereportrelationshipsbetweenbloodpressure
andurinarycadmiumin amultistage stratifiedproba-
bility sample of approximately 1000 adult men and
women from the central and eastern United States.
These individuals compose a subsample ofthe second
U.S. National Health and Nutritional Examination
Survey (NHANES II), conducted during the period
1976 to 1988 (20).
Methods
Subjects
The NHANES II survey assessed health status of
individuals from 64 areas [called primary sampling
units(PSUs)] selectedfrom a stratified sample of1924
geographic areas within the United States. These
areas, which typically consist of one or more contig-
uous counties, were stratified according to region,
racial composition, and degree of urbanization (20).
Within each ofthese 64 PSUs, a nested sampling de-
sign selected census enumeration districts, housing
clusters within districts, households within housing
clusters, and respondents within households. This
design achieved 20,325 responses from a survey of
27,803 noninstitutionalizedciviliansaged6monthsto
74 years. The data include responses to direct medical
examination, medical history, 24-hr dietary recall,WHITTEMORE ET AL.
health-related behavior, and demographic questions.
Systolic and diastolic blood pressure were measured
three times during the examination; at the beginning
withthe subject in a sittingposition; and atthe end, in
both sitting and reclining positions. Procedures were
based on guidelines published by the American Heart
Association (21). Further details on the design ofthis
survey can be found elsewhere (20,22).
Aspart ofacollaboration betweenthe National Cen-
ter for Health Statistics (NCHS) and the U.S. Envi-
ronmental Protection Agency (EPA), NHANES II per-
sonnel collected and aliquoted for cadmium analysis a
single casual urine specimen from a subsample ofap-
proximately 1000 study subjects during 1978-1979.
(Urinary cadmium is regarded as a measure of long-
term accumulation of this element.) Subjects in the
subsamplewere ofboth sexes, 20to 74yearsofage, and
from selected PSUs in nine states (Arkansas, Illinois,
Indiana, Michigan, NewJersey, New York, Ohio, Penn-
sylvania, andTexas). Subjectswerechosentorepresent
the general adult United States population, stratified
by age, sex, and income level.
Urine Analysis
Urine samples were frozen with dry ice within 1 hr
ofcollectionandwereshippedfrozentoaclinical labor-
atory (Swedish Hospital Medical Center, Seattle, WA),
where they were analyzed for cadmium, 12-microglob-
ulin, specific gravity, and creatinine.
Cadmium analysis was performed by chelation and
extraction. A 1-mL portion of2% sodium N,N-diethyl-
dithiocarbamate was mixed with 5 mL urine in a cen-
trifuge tube. Methyl isobutyl ketone (3 mL)was added,
and the tube was mixed, centrifuged for 5 min, and
separated. The organic phase was then analyzed for
cadmium by flameless atomic absorption spectrome-
try, using a Perkin-Elmer 306 instrument with an
HGA-2100 graphite furnace. A calibration curve was
made from spiked composite urine. Analysis was done
in duplicate, with controls ineachrun, and accuracy of
calibration was assessed using National Bureau of
Standards standard reference material SRM 1643.
Adjustment for urine concentration is needed be-
cause subjects provided single (rather than 24-hr)
urine samples. We adjusted the cadmium levels to a
specific gravity of 1.020 as follows: adjusted cadmium
level = 0.020 x sampleurinarycadmiumlevel/(sample
specific gravity - 1.000). Specific gravity was mea-
sured by refractometer.
Statistical Analysis
Multiple linear regression was used to examine rela-
tionships ofurinary cadmium to systolic and diastolic
bloodpressure (arithmetic mean ofthe three measure-
ments taken at interview), adjusted for age, race, rela-
tive body weight, cigarette smoking status, and cur-
rent hypertensive medication use. Multiple logistic
regression was used to examine relationships of uri-
narycadmiumtocurrenthypertensive medicationuse,
adjusted for age, race, weight, and smoking status. Re-
gressionswereperformedusingbothurinarycadmium
andits naturallogarithm. Resultswere similarforthe
two analyses, so we report only those based on the un-
transformed cadmium values.
The design used to subsample subjects for cadmium
analysis precludes variance estimation for regression
coefficients using Taylor series approximations or
balanced-half sample methods (23,24) that accommo-
date the clustered nature ofthe survey. Furthermore,
sampling weights appropriate for subjects in the cad-
mium subsample were not available. Therefore, all p-
values andconfidence limits arebased on the assump-
tion that the cadmium subsample is a simple random
sample ofthe adult U.S. population.
Results
Blood pressure and urinary cadmium levels were
available for a total of960 subjects. Ofthese, four were
excluded because their cadmium levels exceeded 20
Atg/L [considered an upper bound for plausible values
in environmentally exposed individuals (17)], and five
were excluded because their smoking status was un-
known. Table 1 shows summary descriptive statistics
fortheremaining951 subjects. Ahigherfractionofwo-
menthanmenwerenonwhite, usedhypertensivemedi-
cation, and had avoided the cigarette habit. Women
alsohadhigher urinary cadmium levelsthan did men.
Figure 1 shows strong age-related increases in mean
urinary cadmium levels up to age 70 years for both
men and women. An increasing trend ofurinary cad-
mium with age has been noted in several studies
(25,26) and may reflect the increasing body burden of
cadmium with age. Figure 1 also shows a drop in cad-
mium among both men (n = 45) and women (n = 39)
aged 70 to 74 years.
Table 1. Mean characteristics of study subjects.'
Characteristic
Number
Age, years
Race, %
White
Black
Other
Blood pressure
Systolic, mm Hg
Diastolic, mm Hg
Family history ofhypertension, %b
Hypertensive medication use, %
Quetelet's index of relative
body weight, kg/m2c
Cigarette smoking status, %
Current smokers
Former smokers
Lifelong nonsmokers
Urinary cadmium, gg/L
Men
474
46.9 ± 0.8
90.5 ± 1.3
8.6 ± 1.3
0.8 ± 0.4
131.7 ± 0.9
81.4 ± 0.5
42.4 ± 2.3
11.2 ± 0.02
Women
477
47.3 ± 0.8
85.7 ± 1.6
13.2 ± 1.5
1.1 ± 0.5
129.0 ± 1.1
79.0 ± 0.6
45.3 ± 2.3
15.3 ± 0.2
25.6 ± 0.2 25.7 ± 0.3
35.2 ± 0.05
34.4 ± 0.05
30.4 ± 0.05
1.1 ± 0.04
a Values presented as means
± standard error.
bParents or siblings.
cQuetelet's index = weight/height2.
27.9 ± 0.04
15.7 ± 0.03
56.4 ± 0.05
1.3 ± 0.07
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FIGURE 1. Geometric means ofspecific-gravity-adjusted urinary cad-
mium levels versus age.
Cigarettes contain high concentrations ofcadmium
(0.5-2.0 Ag/cigarette) (17,27). Moreover, inhaled cad-
mium is absorbed more readily than ingested cad-
mium (27). Therefore, cigarette smoking is an impor-
tant source of exposure to cadmium. Figure 2 shows
that cadmium levels increase with cigarette smoking
rate among current smokers (p < 0.001). The slope of
thefittedleast squaresregression line was not affected
by adjustment for age.
We next investigate associations between urinary
cadmium and blood pressure. Table 2 presents multi-
ple regression coefficients for blood pressure (systolic
and diastolic) in relation to selected characteristics,
among all participants combined. Both measures of
blood pressure increased nonlinearly with age and in-
creased linearly with Quetelet's index ofrelative body
weight (weight in kilograms divided by the square of
height in meters). By contrast, no significant or con-
sistent effects were seen for sex, race (black vs. non-
black), or cigarette smoking status. (The number of
blacks inthe group was too small toprovide a sensitive
assessment ofracial differences in hypertension). The
coefficients for hypertensive medication use indicate
that users hadhigherdiastolic pressures andconsider-
ably higher systolic pressures than did nonusers.
Table 2 shows that urinary cadmium levels were sig-
nificantly and positively related to both systolic (p <'
0.05) and diastolic (p < 0.01) pressure, after adjust-
ment for the other variables in the table. We added
powers of urinary cadmium levels to the regressions,
FIGURE 2. Urinary cadmium level versus current cigarette smoking
rate amongmen andwomen. Fittedlinehas slope 0.02 (standard
error = 0.01) and intercept 1.03 (0.14).
Table 2. Multiple regression coefficients for three
measures of hypertension in relation to selected
characteristics among 951 participants.
Blood pressure, mm Hg Hypertensive
Characteristic Systolic Diastolic medication use
Number 951 951 951
Age, years 0.23 (0.24)a 0.77 (0.15) 0.29 (0.09)
Age2 x 10 0.07 (0.03) -0.07 (0.02) -0.02 (0.01)
Gender, female -4.08 (1.18) -3.23 (0.70) 0.28 (0.24)
Race, black 0.05 (1.83) -0.78 (1.08) 0.07 (0.35)
Quetelet's index,
km/m' 1.37 (0.12) 0.89 (0.07) 0.09 (0.02)
Cigarette smoking
Former smoker -2.49 (1.50) -0.83 (0.89) 0.01 (0.26)
Current smoker -0.41 (1.38) -0.63 (0.82) -0.48 (0.31)
Family history of
hypertension 2.96 (1.16) 1.96 (0.69) 1.24 (0.22)
Hypertensive
medication use 11.35 (1.81) 3.68 (1.08) - -
Urinary cadmium,
Ag/L 1.16 (0.49) 0.84 (0.29) -0.06 (0.09)
a Standard errors in parentheses.
but found no evidence of nonlinearity in the relation-
ship. The cadmium coefficients and their 95% confi-
dence limits are shown in Figure 3A and C. The figure
3 also shows point estimates and95% confidence inter-
vals for regression coefficients relating blood pressure
tourinary cadmium levels separatelyby sex and smok-
ing status(adjusted for age, race, Quetelet's index, and
current hypertensive medication use). These subgroup-
specific regression coefficients are not consistent.
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FIGURE 3. Estimated regression coefficients and 95% confidence intervals for systolic (A,C) and diastolic (B,D) blood pressure versus urinary
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weight, and family history ofhypertension. Dashed lines indicate overall coefficients, adjusted also for sex and smoking status, and 95%
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Among men, the coefficient is significantly positive
only for diastolic pressure in current smokers. Among
women, significantly positive coefficients are seen for
both systolic anddiastolic pressure incurrentsmokers,
but not for any other comparison.
The positive regression coefficients seen among cur-
rent smokers might reflect a direct association be-
tween blood pressure and smoking rate. However, in
agreement with other findings (28,29) we found no as-
sociations between systolic or diastolic blood pressure
andreported smokingrate incigarettes perday among
current smokers, after adjustment for the other varia-
bles in Table 2. Moreover, the significantly positive re-
gression coefficients noted for urinary cadmium
among current smokers persisted after controlling for
smoking rate.
Some hypertensive treatments appear to increase
the excretion of renal cadmium. For example, Wester
(30) noted increased urinary cadmium concentration
in hypertensives following treatment with chlorthali-
done, and McKenzie and Kay (31) reported greater 24-
hr urinary concentration ofcadmium intreatedhyper-
tensive women compared with a normotensive group.
Therefore, the positive associations seen in Figure 3
might reflect merely iatrogenically elevated urinary
cadmium levels among treated hypertensives. This
possibility is investigated in Figure 3B and D, which
show regression coefficients relating blood pressure to
urinary cadmium levels when individuals who re-
ported using hypertensive medications were deleted
from the analyses. Comparisons with Figure 3A and C
reveal substantial decreases in the regression coeffi-
cientsforboth systolic and diastolic blood pressure. All
coefficients are reduced by a factor oftwo. Only the co-
efficient for systolic pressure in currently smoking
women remains statistically significant.
Figure 4 shows scatter plots ofblood pressure versus
cadmium among current smokers, with those taking
hypertensive medication distinguishedfromother par-
ticipants. Also shown are nonparametric regression
curves for each ofthe two types ofdata (32). The graph
shows several outlying subjects on hypertensive medi-
cation whohave high levelsofboth cadmium andblood
pressure. These individuals have a disproportionate ef-
fect on estimated regression coefficients relating cad-
mium to blood pressure. The large regression coeffi-
cient reductions occasioned by their removal suggests
that the positive associations between cadmium and
hypertension noted here do not reflect a causal mech-
anism, but rather an effect ofhypertensive treatment.
Table 2 presents multiple logistic regression coeffi-
cients relating current hypertensive medication use to
demographic characteristics, body size, smoking stat-
us, and urinary cadmium. Hypertensive medication
users wereolder andheavierfortheirheightthan were
nonusers. However, the two groups did not differ sig-
nificantly with respect to sex, race, or smoking status.
The groups also were similar with respect to urinary
cadmium levels (p = 0.50), despite the presence ofout-
lying userswithhighcadmiumlevels seen inFigure 4.
235 -
227- A 0
219 -
211 -
203- ° °
001, 195 - +ovo , 195 + 0 ,10
187- *C *
SC + _
107 - o
9135
*+
75
Ill, O.,#
-0. 1.5 3- . . . 1. 45 1.
S150- o °
145
De 85 S
14 - 0
n 13 - 5 +
130
- *
j123 0-
K~~~~~~~
60s- ++
510
-
99 - 8
4+
45
I X -I I T I I I I I I
-0.5 1.5 3.5 5.5 7.5 95 11.5 14.5 17.5
URINARY CADMIUM (pgl/)
FIGURE 4. Scatter plot and nonparametric regression curves (32) for
(A) diastolic and (B) systolic blood pressure versus urinary cad-
mium among current smokers who use (o,---) and do not use(+ +,-)
hypertensive medication.
137WHITTEMORE ET AL.
This apparent inconsistency is probably due torobust-
ness ofthe logistic coefficient estimates against occa-
sional high, outlying cadmium levels among users.
Suchrobustness contrasts withthe observed lack ofro-
bustness ofthe ordinary least squares estimates relat-
ing blood pressure levels to urinary cadmium.
Alloftheregressioncoefficientsrelatingcadmiumto
hypertension remained essentially unchanged when
years ofeducation andblood lead levels were included
in the regressions. Since blood lead levels were un-
available for half the participants, inclusion of this
variable in the regressions reduced the sample size by
half. Thuswe have notpresented resultsofregressions
that include blood lead levels.
Discussion
Usingdatafrom 951 participants inthe NHANES II
Survey, we have examined variation of urinary cad-
mium levels with age, sex, and smoking status, and as-
sociations between urinary cadmium levels and blood
pressure levels. Cadmium levels increased with age
and, among smokers, with smoking rate. The positive
associations seen between urinary cadmium and age
are consistent with other findings (18,25). Cadmium
levelsfoundinthekidney andliver atautopsy increase
with age (33). with the kidney containing about one-
third ofthe total body burden (17). Similarly, the posi-
tive association seen between urinary cadmium and
reported cigarette smoking rates among current
smokers is consistent with other observations
(25,26,34,35). The drop in cadmium levels seen in
Figure 1 among older individuals could be related to
an age-related decline in glomerular filtration rate.
Among all participants, statistically significant pos-
itive relationships were seen between urinary cad-
mium levels andboth systolic and diastolicblood pres-
sure, after adjusting for age, sex, race, relative body
weight, smoking status, and hypertensive medication
use. However, analyses by subgroups determined by
sex and smoking status were inconsistent. Among cur-
rent smokers, urinary cadmium levels were positively
associated with both systolic and diastolic blood pres-
sure for women, and with diastolic blood pressure for
men. Yet among former smokers and lifelong non-
smokersofboth sexes, urinarycadmiumwasunrelated
to either systolic or diastolic blood pressure. Further,
whentreated hypertensives were removed from analy-
sis, regression coefficients decreased and lost statisti-
cal significance.
Several study limitations must be considered in in-
terpretingtheresults.First, wecannotexcludethepos-
sibility that relationships of cadmium to blood pres-
sure differed between survey respondents and nonre-
spondents. (The overall response rate forthe NHANES
II survey was 73%.) Second, the cadmium levels are
subject to measurement error. Cadmium measure-
ments were based on a single casual urine specimen
taken at examination; therefore, it was necessary to
adjust the cadmium levels for variable urine concen-
trations. The sampling procedure and the adjustment
are sources of measurement error. Moreover, day-to-
dayvariationincadmiumconcentrationhasbeendem-
onstrated in complete 24-hr specimens(36). The multi-
ple regression analysis used here does not accommo-
date such intrasubject variation in measured urine
cadmium concentrations. Lack of information on the
extent ofsuch variation precludes an analysis that ac-
commodates measurement error for cadmium. In the
presence of such error, ordinary multiple regression
analysis produces coefficients for cadmium that are
biased toward zero (37).
Third, we estimated standard errors for the regres-
sion coefficients under the assumption of simple ran-
dom sampling, with each participant having equal
probability ofbeing sampled. The clustered nature of
the NHANES sampling design introduces correlation
between variables measured on subjects within the
same PSU. Positive correlation can bias variance esti-
mates downward, thereby exaggerating significance
levels. Although empirical and theoretical studies
have shownthat the bias in variances ofregression co-
efficients islikely tobe small, itseffect inthis study is
unknown. The limited number ofPSUs used to select
subjectsforcadmium analysishasprecludedthe use of
methods(23,24)toobtainunbiasedvarianceestimates.
(We repeated the blood pressure regressions using a
modelwithsubjects' PSUstakenasrandomeffects and
all other independent variables taken as fixed effects.
Such a model allowspositive covariance betweenblood
pressure measurements for subjects within the same
PSU, but it assumes unrealistically that the covari-
ance is constant across all pairs ofsubjects and across
all PSUs. As expected, variances ofthe estimated cad-
miumcoefficientsincreasedinthismodel, andtheesti-
mates lost statistical significance.)
Despite the aforementioned limitations, the positive
associations seen between cadmium and blood pres-
sure among current smokers require interpretation.
Concern about a possible causal effect ofcadmium on
hypertension arises because cadmium accumulates in
therenalcortex(17)andhasbeenassociatedwithrenal
damage (38-40). Cadmium-induced renal damage has
been conjectured to cause hypertension by increasing
the retention ofsalts and water and/or the production
ofangiotensin, a powerful vasoconstrictor. Yet few bio-
logical explanations come to mindfor acausal associa-
tion between cadmium and hypertension that is limit-
ed to current smokers. Confounding by hypertensive
treatment is a more likely explanation for the present
findings, because the subgroup ofcurrent smokers in-
cluded treated hypertensives with very high levels of
both cadmium and blood pressure. These individuals
greatly influenced the estimated regression coeffi-
cients, even in analyses that stratified on medication
use. Indeed, little evidence for anassociation persisted
after their removal from the analysis. The possible
causal pathway from hypertensive treatment to ele-
vated urinary cadmium levels illustrates the difficul-
ties of causal inference from cross-sectional data.
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Other epidemiologic data relating systemic cad-
mium levels tohypertension alsoare conflicting. Some
studies have found higher blood cadmium levels in hy-
pertensivethaninnormotensive adults(9,11,12), while
othershavefoundnodifferences(41). Thepositivefind-
ings are difflcult to interpret because the comparisons
were not controlled fordifferences in age and smoking
statusbetweenhypertensives andnormotensives. Sim-
ilarly, no clear picture has emerged from comparisons
between hypertensives and normotensives in renal
cadmium concentrations measured either at autopsy
(8,10,15) or in vivo (13). Failure to control for age and
smoking status also complicates these comparisons. It
is noteworthy that a slight negative association be-
tween urinary cadmium levels and blood pressure was
found in a population-based Belgian study (16) which,
like the present one, excluded treated hypertensives
and controlled for age, smoking status, and obesity.
In summary, existing datadonotsupport acausal re-
lationship between cadmium exposure and elevated
bloodpressure amongadultswhoare notoccupational-
ly exposed to cadmium or treated for hypertension.
Elucidation ofsuch a potential causal relationship re-
quires further research incorporating control for the
potential confounding effects of age, cigarette smok-
ing, and hypertensive medication use. The Third Na-
tional Health and Nutrition Examination Survey, con-
ducted during the period 1988 to 1994, will include
cadmium analysis ofurine samples for approximately
30,000 adult participants. These data will be useful in
resolving the issues raised here.
This research was supported by a grant to SIMS from the U.S. En-
vironmental Protection Agency.
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